LARIMAR THERAPEUTICS, INC.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
S-8 Mar 24, 2025 S-8
10-K Mar 24, 2025 10-K
8-K Mar 24, 2025 8-K
SCHEDULE 13G Feb 4, 2025
8-K Jan 27, 2025 8-K
4 Jan 24, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Jan 24, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Jan 24, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Jan 24, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
8-K Jan 10, 2025 8-K
SCHEDULE 13G/A Jan 8, 2025
8-K Dec 16, 2024 8-K
8-K Nov 18, 2024 8-K
SC 13G/A Nov 14, 2024 SC 13G/A
SC 13G/A Nov 14, 2024 JANUS AMENDMENT
SC 13G/A Nov 14, 2024
SC 13G Nov 6, 2024
10-Q Oct 30, 2024 10-Q
8-K Oct 30, 2024 8-K
10-Q Aug 8, 2024 10-Q
8-K Aug 7, 2024 8-K
8-K Jun 10, 2024 8-K
4 Jun 3, 2024
4 May 31, 2024 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 May 31, 2024 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
← Newer Page 4 of 28 · 693 filings Older →